Blueprint Medicines Corporation (BPMC)

Jul 18, 2025 - BPMC was delisted (reason: acquired by SNY)

129.46

0.00 (0.00%)

Inactive · Last trade price on Jul 17, 2025

Blueprint Medicines Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	562.12	508.82	249.38	204.04	180.08	793.74
Revenue Growth	99.19%	104.04%	22.22%	13.30%	-77.31%	1093.37%
Gross Profit	542.35	488.66	236.58	177.28	154.35	793.31
Operating Income	-174.31	-212.04	-486.28	-537.52	-641.98	308.71
Net Income	-155.73	-67.09	-506.98	-557.52	-644.09	313.88
Earnings Per Share	-2.45	-1.07	-8.37	-9.35	-11.01	5.59
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Collaboration and License	-	29.87	45.17	65.54	122.39	771.6
AYVAKIT/AYVAKYT	535.84	478.95	204.21	110.99	52.98	21.26
Other	-	-	0.18	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	899.78	863.94	767.17	1,078	1,035	1,550
Total Debt	713.33	724.28	774.12	672.78	111.41	89.6
Net Cash (Debt)	186.45	139.66	-6.95	405.69	923.24	1,460
Net Cash Growth	35.43%	-	-	-56.06%	-36.77%	223.03%
Net Cash Per Share	2.94	2.22	-0.11	6.80	15.78	26.00

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-145.55	-192.59	-436.85	-502.28	-298.65	387.04
Capital Expenditures	-5.36	-4.63	-16.06	-8.92	-3.09	-3.16
Free Cash Flow	-150.91	-197.22	-452.91	-511.2	-301.74	383.88
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	96.48%	96.04%	94.87%	86.88%	85.71%	99.95%
Operating Margin	-31.01%	-41.67%	-194.99%	-263.44%	-356.50%	38.89%
Pretax Margin	-27.38%	-12.94%	-202.91%	-270.68%	-356.00%	39.68%
Profit Margin	-27.70%	-13.18%	-203.30%	-273.24%	-357.67%	39.55%
FCF Margin	-26.85%	-38.76%	-181.61%	-250.54%	-167.56%	48.36%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 8, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PE Ratio	-	-	-	-	-	19.91
P/FCF Ratio	-	-	-	-	-	16.28
PS Ratio	-	10.89	22.49	12.85	35.00	7.87